Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost sodium plus aspirin for prevention of atherosclerosis progression in type 2 diabetes
ChiCTR-TRC-10000919Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Apr 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of beraprost and aspirin in atherosclerosis (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Change rate of intima-media thickness. Started Apr 2010; status: completed.
02
Drugs
beraprostaspirin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-10000919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000919.